FDMT · 4D Molecular Therapeutics, Inc.

$9.87 +0.26 (+2.65%)

Market Cap

$665.13M

69.21M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-09	Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-05-19	RBC 2026 Global Healthcare Conference	Conference
2026-05-13	BofA Securities 2026 Healthcare Conference	Conference
2026-03-25	Leerink Partners Mountain Meeting	Event
2026-03-24	RBC Capital Markets Global Ophthalmology Conference	Conference
2026-03-12	Barclays 28th Annual Global Healthcare Conference	Conference
2026-03-10	Leerink Global Healthcare Conference	Conference
2026-03-03	TD Cowen 46th Annual Health Care Conference	Conference
2026-01-14	44th Annual J.P. Morgan Healthcare Conference	Conference
2025-12-17	AEROW Phase 1 Interim Data for 4D-710 in Cystic Fibrosis	Event
2025-12-03	8th Annual Evercore Healthcare Conference	Conference
2025-11-18	Jefferies 2025 London Healthcare Conference	Conference
2025-10-21	Chardan’s 9th Annual Genetic Medicines Conference	Conference
2025-09-09	Morgan Stanley Annual Global Healthcare Conference	Conference
2025-09-09	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-09-04	Cantor Global Healthcare Conference 2025	Conference
2025-08-13	H.C. Wainwright 5th Annual Ophthalmology Virtual Conference	Conference
2025-06-11	46th Annual Goldman Sachs Global Healthcare Conference	Conference
2025-06-04	Jefferies Global Healthcare Conference	Conference
2025-05-14	BofA Securities 2025 Healthcare Conference	Conference

Source: https://ir.4dmoleculartherapeutics.com/

Key facts CIK 1650648 CUSIP 35104E100 13F (30d) 22 filings 22 filers Visit website Investor relations